Accuracy to 2nd International HIV-1 RNA WHO Standard: Assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests

Journal of Clinical Virology

Volumn 50, Issue 2, 2011, Pages 119-124

  Glaubitz, Joachim ^a   Sizmann, Dorothea ^a   Simon, Christian O ^a   Hoffmann, Konstanze S ^a   Drogan, Daniel ^a   Hesse, Martin ^a   Lang, Gabriele ^a   Kroeh, Michael ^a   Simmler, Pascale ^a   Dewald, Manuela ^a   Haberhausen, Gerd ^a   Lindauer, Andreas ^b   Beyser, Kurt ^b   Reber, Achim ^b   Baumeister, Andreja ^c   Wolf, Eva ^d   Jaeger, Hans ^c   Babiel, Reiner ^a  

^a Roche Diagnostics Ltd   (Switzerland)

^b SYNLAB ACADEMY   (Germany)

^c Dr Wilhelm Krüsmann Gynäkologische Endokrinologie und Sterilitätsmedizin zertifiziert nach DIN EN ISO 9001   (Germany)

^d MUC Research GmbH and MVZ Karlsplatz   (Germany)

Author keywords

Accuracy; HIV; Quantitation; Traceability; Viral load; WHO Standard

Indexed keywords

VIRUS RNA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 TEST; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA ANALYSIS; WORLD HEALTH ORGANIZATION;

HIV INFECTIONS; HIV-1; HUMANS; LIMIT OF DETECTION; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; WORLD HEALTH ORGANIZATION;

EID: 78951479376     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.10.017     Document Type: Article

References (20)

1. Valentine-Thon E. Quality control in nucleic acid testing-where do we stand?. J Clin Virol 2002, 25:13-21.
2. Saldanha J. Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. J Clin Virol 2001, 20:7-13.
3. Holmes H., Davis C., Heath A., Hewlett I., Lelie N. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001, 92:141-150.
4. Davis C., Berry N., Heath A., Holmes H. An international collaborative study to establish a replacement World Health Organization International Standard for human immunodeficiency virus 1 RNA nucleic acid assays. Vox Sanguinis 2008, 95:218-225.
5. Braun P., Ehret R., Wiesmann F., Zabbai F., Knickmann M., Kühn R., et al. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin Chem Lab Med 2007, 45(1):93-99.
6. Richman D.D. HIV chemotherapy. Nature 2001, 410:995-1001.
7. Sudharshan S., Biswas J. Introduction and immunopathogenesis of acquired immune deficiency syndrome. Indian J Ophthalmol 2008, 56:357-362.
8. Palmer S., Wiegand A.P., Maldarelli F., Bazmi H., Mican J.M., Polis M., et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2003, 41:4531-4536.
9. ® system. J Clin Virol 2007, 38:304-312.
10. Kwok S., Sninsky J.J. PCR detection of human immunodeficiency virus type 1 proviral DNA sequences. Diagnostic molecular biology: principles and applications 1993, ASM, Washington, DC. D.H. Persing, T.F. Smith, F.C. Smith (Eds.).
11. Laprevotte I., Pupin M., Coward E., Didier G., Terzian C., Devauchelle C., et al. HIV-1 and HIV-2 LTR nucleotide sequences: assessment of the alignment by N-block presentation " retroviral signatures" of overrepeated oligonucleotides, and a probable important role of scrambled stepwise duplications/deletions in molecular evolution. Mol Biol Evol 2001, 18:1231-1245.
12. ® HIV-1 Test for HIV-1 viral load quantification. J Clin Microbiol. 2010, [Epub ahead of print].
13. ®HIV-1 Test, v2.0 using a novel dual-target approach. J Clin Virol 2010, 49:41-46.
14. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009. p. 1-161. Available at: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
15. Clavel F., Hoggan M.D., Willey R.L., Strebel K., Martin M.A., Repaske R. Genetic recombination of human immunodeficiency virus. J Virol 1989, 63:1455-1459.
16. ® HIV-1 assays. J Clin Microbiol 2007, 45:3436-3438.
17. Jaeger H., Wolf E., Simon C.O., Babiel R. Traceability of three generations of nucleic acid amplification tests (NAT) for quantitative HIV-1 RNA measurements to the WHO HIV-1 RNA International Standards. J Acquir Immune Defic Syndr 2010, 54:334-335.
18. Lima V., Harrigan R., Montaner J.S. Increased reporting of detectable plasma HIV-1 RNA Levels at the critical threshold of 50 copies per milliliter with the TaqMan assay in comparison to the amplicor assay. J Acquir Immune Defic Syndr 2009, 51:3-6.
19. Gatanaga H., Tsukada K., Honda H., Tanuma J., Yazaki H., Watanabe T., et al. Detection of HIV type 1 load by the Roche COBAS TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor. Clin Infect Dis 2009, 48:260-262.
20. ® HIV-1 test version 2.0 for the quantification of HIV-1 RNA. J Clin Microbiol 2010, [Epub ahead of print].